Product Information
SULFACETAMIDE SOD 10% TOP SUSP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.5150 per ML under NDC 45802089626. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 23, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802089626
Classification
Generic
Dosage Form
LOTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078649FDA Approved
3/23/2009
TE Code
AB
On Market Since
10/17/2012
Pharmacological Classes
Price Statistics
The NADAC for SULFACETAMIDE SOD 10% TOP SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5150 per ML |
|---|---|
| All-time high | $1.2631 (Nov 16, 2016) |
| All-time low | $0.4848 (Nov 20, 2024) |
| 52-week high | $0.7587 |
| 52-week low | $0.5150 |
| Median price | $0.6985 |
| Average price | $0.7752 |
| Largest weekly change | +62.5% (Dec 22, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sulfacetamide Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sulfacetamide Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFACETAMIDE SOD 10% TOP SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SULFACETAMIDE SOD 10% TOP SUSP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.5150 per ML (NDC 45802089626), effective Sep 30, 2026.
How has the price of SULFACETAMIDE SOD 10% TOP SUSP changed over time?
Over the history we have for it, the NADAC for SULFACETAMIDE SOD 10% TOP SUSP has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SULFACETAMIDE SOD 10% TOP SUSP?
Since Nov 28, 2013, the NADAC for SULFACETAMIDE SOD 10% TOP SUSP has ranged from a low of $0.4848 (Nov 20, 2024) to a high of $1.2631 (Nov 16, 2016), with a median of $0.6985 per ML.
Are there cheaper alternatives to SULFACETAMIDE SOD 10% TOP SUSP?
No other NADAC-published product currently shares the active ingredient and strength of SULFACETAMIDE SOD 10% TOP SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SULFACETAMIDE SOD 10% TOP SUSP?
SULFACETAMIDE SOD 10% TOP SUSP (NDC 45802089626) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.